Navigation Links
Inspire Announces Presentations at 2007 Association for Research in,Vision and Ophthalmology Annual Meeting

nformation regarding factors that could affect Inspire's results is included in Inspire's filings with the SEC. Inspire undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof.

Contact

Investor Contact:
Inspire Pharmaceuticals, Inc.
Jenny Kobin,
VP, Investor Relations and Corporate Communications
919-941-9777, Ext. 219
or
Media Contact:
BMC Communications
Dan Budwick, 212-477-9007, Ext. 14


'"/>




Page: 1 2 3

Related medicine technology :

1. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
2. Inspire Announces Presentations at Two European Scientific Conferences
3. Inspire Announces Positive Results of Phase 2 Trial of Epinastine Nasal Spray for Seasonal Allergic Rhinitis
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease

Post Your Comments:
(Date:12/2/2009)...EIDELBERG, Germany, Dec. 2 febit,s...rs of the "Top 10 Innovations of 2009" by The Sci... capture technology for high-throughput sequencing...of invention, vision and utility. ,, The Scie...te a broad range of life science technologies and ...
(Date:12/2/2009)... TeamHealth Teleradiology ( www.th...rgest provider of hospital-based clinical outsourc...ide teleradiology services for two groups in South...with UpState Carolina Radiology located in Spartan... provide services for the following four hospitals...
(Date:12/2/2009)...RNewswire/ -- Decision Resources, one of the world...eutical and healthcare issues, finds that generic ...tipsychotics will cause the schizophrenia drug mar...billion in 2013 in the United States, France, Germ..., The new Pharmacor report entitled Schizophre...
Breaking Medicine Technology:The Scientist Magazine Recognizes febit's HybSelect(TM) Among the Winners of 'Top 10 Innovations of 2009' 2TeamHealth Teleradiology Announces New Contracts in South Carolina and Illinois 2Generic Erosion of Established Branded Atypical Antipsychotics Will Cause the Schizophrenia Drug Market To Decline More Than $1 Billion by 2013 2Outsmarting Brain Tumors 3A Cedars Sinai Researchers Neurosurgeons and Other Experts Present Free Conference for Adult Brain Tumor Patients and Careg 47564 1Outsmarting Brain Tumors 3A Cedars Sinai Researchers Neurosurgeons and Other Experts Present Free Conference for Adult Brain Tumor Patients and Careg 47564 2Researchers at the Karmanos Cancer Institute in Detroit Discover Feasibility of Chemotherapy Alternative 4510 1Researchers at the Karmanos Cancer Institute in Detroit Discover Feasibility of Chemotherapy Alternative 4510 2Researchers at the Karmanos Cancer Institute in Detroit Discover Feasibility of Chemotherapy Alternative 4510 3Nature parks can save species as climate changes 12401 1Nature parks can save species as climate changes 12401 2Nature parks can save species as climate changes 12401 3
...AMBRIDGE, England, 4th May 2007 - CeNeS Pharmaceut...aceutical company, notes,the publication of an ind... ,Synapse,* on its Phase II NMDA antagonist, CNS 5...reatment for neuropathic,pain. The independent stu...taken with CNS 5161. , In the study reported in ,S...
...mpany Conference Call Scheduled for Friday, May 4,...ANCISCO, May 03, 2007 /PRNewswire-FirstCall/ --,Me...the mild and,moderate subgroups of Alzheimer,s dis...fficacy study of Dimebon showed that both,subgroup...ents on,all five efficacy endpoints studied. , The...
Other Medicine Technology:Independent publication supports the profile of CeNeS phase II,compound, CNS 5161 2Independent publication supports the profile of CeNeS phase II,compound, CNS 5161 3Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 2Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 3Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 4Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 5
(Date:12/2/2009)...ancer patients who have a prostate-specific antige...years after external beam radiation therapy (EBRT)...ancer-related death, according to a study in the D...diation Oncology*Biology*Physics, the official jou...y (ASTRO)., PSA levels in a prostate cancer pati...
(Date:12/2/2009)... National Pen ( www.pens.com ), a wor...unced today it is giving away 10,000 free business...ember 2, 2009 -- National Pen ( www.pens.com ), a ...nounced today it is giving away 10,000 free busine...o promote business that no other company in the in...
(Date:12/2/2009)... National Race Series to increase awa...r families on the importance of early detection ,...er 2, 2009 -- Men, women, families, friends and ne...invited to participate in the Rudolph Ramble 5K. ...ACE Race Series , which was launched by the Prost...
(Date:12/2/2009)...CHICAGO, Dec. 2 The Ame...Board of Directors today announced Alan F. Dowling...000-member health information management (HIM) lea...xperience includes academia, systems management, s...ot-for-profit executive leadership. He is schedul...
(Date:12/2/2009)... $1 Million - 4 State Campaign Features Small Bus... Businesses and Would Kill Jobs ,, WASHINGTON,...e House jobs summit scheduled for Thursday, Keepin...te for Liberty, today announced a new $1 million 4...fects of the current health care legislation on sm...
Breaking Medicine News(10 mins):Health News:PSA value at 2 years post-treatment can predict long-term survival in prostate cancer patients 2Health News:National Pen Giving Away 10,000 Business Card Pens 2Health News:PACE Race Returns with Denver's Rudolph Ramble 2Health News:PACE Race Returns with Denver's Rudolph Ramble 3Health News:PACE Race Returns with Denver's Rudolph Ramble 4Health News:Dr. Alan F. Dowling Named AHIMA's Next Chief Executive Officer 2Health News:With White House Jobs Summit This Week KSBH Unveils New TV Ads Targeting Senators on Health Care 2Health News:With White House Jobs Summit This Week KSBH Unveils New TV Ads Targeting Senators on Health Care 3Health News:With White House Jobs Summit This Week KSBH Unveils New TV Ads Targeting Senators on Health Care 4
..., a spinal,technology development company whose fo...d today the national launch of the STATURE Vertebr...adiolucent MIS compatible spacer,system designed t...rk and clinical evaluation, it is,rewarding to see...
... . , , Montreal, May 22, 2008 Expectant mothers...their first trimester, according to a new study fr...tal published in the May edition of the British Jo...stigate the impact of antidepressant use during th...
....,(NYSE: PRE ) today announced that it intends to...iary PartnerRe Finance A LLC, $250 million of,10-y...s currently effective,shelf registration statement...ng to,repay all of the $220 million of third-party...
...ach of Novel Technology, N. BILLERICA, Mass., May...urement of cellular bioenergetics, announced today...ive supplier of Seahorse,XF instruments and consum...m by Takeda,Pharmaceutical Company and with its in...
...p,Inc. (Nasdaq: NYER ) reported results for the t... three months ended March 31, 2008 increased $1.55...lion as reported for the,same period last year. Ne...riod ended March 31, 2007. The net loss reflects,c...
... and BREASTCANCER.ORG founder, in,open letter to C...ion ACT, H.R. 758, ...ectomies is an unconscionable practice that can en...tcancer.org, in,an open letter to Congress today a...
Other Medicine News:Health News:Atlas Spine Launches Stature(TM) Vertebral Body Replacement System 2Health News:PartnerRe Ltd. to Issue $250 million in 6.875% Senior Notes 2Health News:PartnerRe Ltd. to Issue $250 million in 6.875% Senior Notes 3Health News:Seahorse Bioscience Enters into Agreement with Primetech Corporation to Bring XF Technology to Japanese Market 2Health News:Nyer Medical Group, Inc. Reports Revenues of $18.9 Million With Net Loss of $.16 Per Share for 3rd Quarter of Fiscal Year 2008 2Health News:Nyer Medical Group, Inc. Reports Revenues of $18.9 Million With Net Loss of $.16 Per Share for 3rd Quarter of Fiscal Year 2008 3Health News:Drive-Through Mastectomies Threaten Patients' Lives 2
TSH Receptor (TSHR) Autoantibody - RIA
TSH Receptor (TSHR) Autoantibody - ELISA
TSH Receptor (TSHR) Autoantibody Coated-Tube (CT)
Thyroid Peroxidase (TPO) Autoantibody - RIA
Medicine Products: